Home > PS Ratio > CONCORD BIOTECH

CONCORD BIOTECH
PS (Price/Sales) Ratio

The Current P/S Ratio of CONCORD BIOTECH is 17.55.

Share Price ₹2,013.5Jun 09,2025
Market Cap ₹21,060.7 Cr
Sales-TTM₹1,200.1 CrTTM-Consolidated Results
Price/Sales17.55xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of CONCORD BIOTECH

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of CONCORD BIOTECH is calculated as :

Current Market Cap [ ₹21,060.7 Cr] as on Jun 09,2025

(/) Sales [ ₹1,200.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 17.55x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for CONCORD BIOTECH , the investors are currently willing to pay '17.55 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD BIOTECH !

The chart below summarizes the trend in P/S Ratio of CONCORD BIOTECH over the last five years.

Historical PS (Price/Sales) ratio chart of CONCORD BIOTECH


PS Ratio Performance Analysis for CONCORD BIOTECH

- CONCORD BIOTECH 's latest p/e ratio is 17.55x.

- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.13x.

- CONCORD BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 15.66x.

- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does CONCORD BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
CONCORD BIOTECH 1,200.117.5521,060.7
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.73406,519.0
DIVIS LABORATORIES LTD9,360.018.79175,903.0
CIPLA LTD27,547.64.42121,669.0
TORRENT PHARMACEUTICALS LTD11,516.09.34107,605.0
DR REDDYS LABORATORIES LTD32,643.93.37110,097.0
MANKIND PHARMA LTD12,279.37.9297,239.7
ZYDUS LIFESCIENCES LTD23,241.54.2197,951.9
LUPIN LTD22,707.94.0191,051.4
AUROBINDO PHARMA LTD31,723.72.1367,457.2
ABBOTT INDIA LTD6,409.210.5567,600.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD BIOTECH 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.13x
Max industry PS 18.79x
Median industry PS 7.73x
Average industry PS 8.18x



You may also like the below Video Courses